UH MacDonald Women's Hospital Division of Gynecologic Oncology's guiding principle is not treating cancer, but treating women with cancer.
Play this video to learn how this rare heated chemo is becoming a new therapy for gynecologic cancers.
Patients are an integral part of the decision-making process and, in all cases, a top priority is given to preserving a women's physical and emotional health.
Women who receive their care at University Hospitals Ireland Cancer Center now University Hospitals Seidman Cancer Center benefit from having treatment coordinated by gynecologic oncologists specializing in the evaluation and management of women with suspected or confirmed gynecologic malignancies.
The division's gynecologic oncologists collaborate with other team members at UH Seidman Cancer Center including chemotherapy nurse specialists, social workers, psychotherapists, and an office staff aware of the special concerns of women with gynecologic cancers. Management for each woman is individualized and may include surgery, chemotherapy, radiation therapy, care of treatment-related side effects and, when needed, coordination of hospice or palliative care.
Our Gynecologic Oncologists are members of the National Institutes of Health-sponsored Gynecologic Oncology Group (GOG), thus UH Seidman Cancer Center patients also have access to the latest development NIH-sponsored clinical research. These include trials for women with newly diagnosed or recurrent cancers, as well as studies aimed at preventing gynecologic cancers or improving the accuracy of early diagnosis. One trial is now enrolling women at high risk for ovarian cancer that is designed to detect the disease in its earliest stage or prevent it from developing at all. At any given time the Division has between 25 and 30 open clinical trials.
The Division's members hold leadership roles in the GOG and participate in its cooperative clinical trials. In addition to its ongoing GOG studies, the Division also focuses on developing investigator-initiated trials.